Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Free Cash Flow (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Free Cash Flow data on record, last reported at -$6.2 million in Q4 2025.

  • For Q4 2025, Free Cash Flow rose 49.39% year-over-year to -$6.2 million; the TTM value through Dec 2025 reached -$33.5 million, up 51.08%, while the annual FY2025 figure was -$33.5 million, 51.08% up from the prior year.
  • Free Cash Flow reached -$6.2 million in Q4 2025 per QTTB's latest filing, down from -$3.7 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $15.9 million in Q3 2023 and bottomed at -$32.8 million in Q4 2021.
  • Average Free Cash Flow over 5 years is -$17.4 million, with a median of -$17.1 million recorded in 2024.
  • Peak YoY movement for Free Cash Flow: soared 163.76% in 2023, then tumbled 223.14% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$32.8 million in 2021, then increased by 17.03% to -$27.2 million in 2022, then soared by 59.09% to -$11.1 million in 2023, then decreased by 9.69% to -$12.2 million in 2024, then surged by 49.39% to -$6.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were -$6.2 million in Q4 2025, -$3.7 million in Q3 2025, and -$10.9 million in Q2 2025.